Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1997 Apr 15;323(Pt 2):387–392. doi: 10.1042/bj3230387

Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells.

T Nakano 1, K Kawamoto 1, J Kishino 1, K Nomura 1, K Higashino 1, H Arita 1
PMCID: PMC1218331  PMID: 9163328

Abstract

Gas6 (encoded by growth-arrest-specific gene 6) is a gamma-carboxyglutamic acid (Gla)-containing protein which is released from growth-arrested vascular smooth muscle cells (VSMCs) and potentiates VSMC proliferation induced by Ca2+-mobilizing growth factors, but not that induced by receptor tyrosine kinases. In this study we examined the importance of Gla residues for the biological activities of Gas6 and tried to assess the importance of endogenous Gas6 in VSMC proliferation. We demonstrated that Gla-deficient Gas6 lacked receptor-binding and growth-potentiating activities. Therefore the vitamin K-dependent modification of Gas6 appeared to be essential for its biological activities. Next we used warfarin, an inhibitor of vitamin K-dependent gamma-carboxylation, to estimate the contribution of endogenous Gas6 to VSMC proliferation. Warfarin markedly inhibited the thrombin-induced proliferation of VSMC without affecting the mRNA or protein expression of Gas6. Therefore the inhibition seems to be due to prevention of the vitamin K-dependent modification of Gas6. However, warfarin did not affect epidermal growth factor-induced proliferation. A neutralizing antibody against Gas6 gave a similar result, i.e. it inhibited thrombin-induced VSMC proliferation but not that induced by epidermal growth factor. These results indicate that endogenously produced Gas6 is very important for VSMC proliferation induced by Ca2+-mobilizing growth factors.

Full Text

The Full Text of this article is available as a PDF (385.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arita H., Hanasaki K., Nakano T., Oka S., Teraoka H., Matsumoto K. Novel proliferative effect of phospholipase A2 in Swiss 3T3 cells via specific binding site. J Biol Chem. 1991 Oct 15;266(29):19139–19141. [PubMed] [Google Scholar]
  2. Borowski M., Furie B. C., Bauminger S., Furie B. Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid. Conformation-specific antibodies directed against the phospholipid-binding site on prothrombin. J Biol Chem. 1986 Nov 15;261(32):14969–14975. [PubMed] [Google Scholar]
  3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  4. Church G. M., Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991–1995. doi: 10.1073/pnas.81.7.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fujimoto J., Yamamoto T. brt, a mouse gene encoding a novel receptor-type protein-tyrosine kinase, is preferentially expressed in the brain. Oncogene. 1994 Mar;9(3):693–698. [PubMed] [Google Scholar]
  6. Godowski P. J., Mark M. R., Chen J., Sadick M. D., Raab H., Hammonds R. G. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell. 1995 Aug 11;82(3):355–358. doi: 10.1016/0092-8674(95)90424-7. [DOI] [PubMed] [Google Scholar]
  7. Goruppi S., Ruaro E., Schneider C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene. 1996 Feb 1;12(3):471–480. [PubMed] [Google Scholar]
  8. Graham D. K., Dawson T. L., Mullaney D. L., Snodgrass H. R., Earp H. S. Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ. 1994 Jun;5(6):647–657. [PubMed] [Google Scholar]
  9. Janssen J. W., Schulz A. S., Steenvoorden A. C., Schmidberger M., Strehl S., Ambros P. F., Bartram C. R. A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene. 1991 Nov;6(11):2113–2120. [PubMed] [Google Scholar]
  10. Jia R., Hanafusa H. The proto-oncogene of v-eyk (v-ryk) is a novel receptor-type protein tyrosine kinase with extracellular Ig/GN-III domains. J Biol Chem. 1994 Jan 21;269(3):1839–1844. [PubMed] [Google Scholar]
  11. Lai C., Gore M., Lemke G. Structure, expression, and activity of Tyro 3, a neural adhesion-related receptor tyrosine kinase. Oncogene. 1994 Sep;9(9):2567–2578. [PubMed] [Google Scholar]
  12. Malhotra O. P., Nesheim M. E., Mann K. G. The kinetics of activation of normal and gamma-carboxyglutamic acid-deficient prothrombins. J Biol Chem. 1985 Jan 10;260(1):279–287. [PubMed] [Google Scholar]
  13. Manfioletti G., Brancolini C., Avanzi G., Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol. 1993 Aug;13(8):4976–4985. doi: 10.1128/mcb.13.8.4976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mark M. R., Chen J., Hammonds R. G., Sadick M., Godowsk P. J. Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl. J Biol Chem. 1996 Apr 19;271(16):9785–9789. doi: 10.1074/jbc.271.16.9785. [DOI] [PubMed] [Google Scholar]
  15. Mark M. R., Scadden D. T., Wang Z., Gu Q., Goddard A., Godowski P. J. rse, a novel receptor-type tyrosine kinase with homology to Axl/Ufo, is expressed at high levels in the brain. J Biol Chem. 1994 Apr 8;269(14):10720–10728. [PubMed] [Google Scholar]
  16. Nakano T., Higashino K., Kikuchi N., Kishino J., Nomura K., Fujita H., Ohara O., Arita H. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J Biol Chem. 1995 Mar 17;270(11):5702–5705. doi: 10.1074/jbc.270.11.5702. [DOI] [PubMed] [Google Scholar]
  17. Nakano T., Kawamoto K., Higashino K., Arita H. Prevention of growth arrest-induced cell death of vascular smooth muscle cells by a product of growth arrest-specific gene, gas6. FEBS Lett. 1996 May 27;387(1):78–80. doi: 10.1016/0014-5793(96)00395-x. [DOI] [PubMed] [Google Scholar]
  18. Nakano T., Kishino J., Arita H. Characterization of a high-affinity and specific binding site for Gas6. FEBS Lett. 1996 May 27;387(1):75–77. doi: 10.1016/0014-5793(96)00394-8. [DOI] [PubMed] [Google Scholar]
  19. Nelsestuen G. L., Kisiel W., Di Scipio R. G. Interaction of vitamin K dependent proteins with membranes. Biochemistry. 1978 May 30;17(11):2134–2138. doi: 10.1021/bi00604a017. [DOI] [PubMed] [Google Scholar]
  20. O'Bryan J. P., Frye R. A., Cogswell P. C., Neubauer A., Kitch B., Prokop C., Espinosa R., 3rd, Le Beau M. M., Earp H. S., Liu E. T. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol. 1991 Oct;11(10):5016–5031. doi: 10.1128/mcb.11.10.5016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ohara O., Nakano T., Teraoka H., Arita H. cAMP negatively regulates mRNA levels of actin and tropomyosin in rat cultured vascular smooth muscle cells. J Biochem. 1991 Jun;109(6):834–839. doi: 10.1093/oxfordjournals.jbchem.a123467. [DOI] [PubMed] [Google Scholar]
  22. Ohashi K., Honda S., Ichinomiya N., Nakamura T., Mizuno K. Molecular cloning and in situ localization in the brain of rat sky receptor tyrosine kinase. J Biochem. 1995 Jun;117(6):1267–1275. doi: 10.1093/oxfordjournals.jbchem.a124854. [DOI] [PubMed] [Google Scholar]
  23. Ohashi K., Mizuno K., Kuma K., Miyata T., Nakamura T. Cloning of the cDNA for a novel receptor tyrosine kinase, Sky, predominantly expressed in brain. Oncogene. 1994 Mar;9(3):699–705. [PubMed] [Google Scholar]
  24. Ohashi K., Nagata K., Toshima J., Nakano T., Arita H., Tsuda H., Suzuki K., Mizuno K. Stimulation of sky receptor tyrosine kinase by the product of growth arrest-specific gene 6. J Biol Chem. 1995 Sep 29;270(39):22681–22684. doi: 10.1074/jbc.270.39.22681. [DOI] [PubMed] [Google Scholar]
  25. Paris S., Chambard J. C., Pouysségur J. Tyrosine kinase-activating growth factors potentiate thrombin- and AIF4- -induced phosphoinositide breakdown in hamster fibroblasts. Evidence for positive cross-talk between the two mitogenic signaling pathways. J Biol Chem. 1988 Sep 15;263(26):12893–12900. [PubMed] [Google Scholar]
  26. Rescigno J., Mansukhani A., Basilico C. A putative receptor tyrosine kinase with unique structural topology. Oncogene. 1991 Oct;6(10):1909–1913. [PubMed] [Google Scholar]
  27. Simon M. I., Strathmann M. P., Gautam N. Diversity of G proteins in signal transduction. Science. 1991 May 10;252(5007):802–808. doi: 10.1126/science.1902986. [DOI] [PubMed] [Google Scholar]
  28. Skogen W. F., Esmon C. T., Cox A. C. Comparison of coagulation factor Xa and des-(1-44)factor Xa in the assembly of prothrombinase. J Biol Chem. 1984 Feb 25;259(4):2306–2310. [PubMed] [Google Scholar]
  29. Straight D. L., Sherrill G. B., Noyes C. M., Trapp H. G., Wright S. F., Roberts H. R., Hiskey R. G., Griffith M. J. Structural and functional characteristics of activated human factor IX after chemical modification of gamma-carboxyglutamic acid residues. J Biol Chem. 1985 Mar 10;260(5):2890–2893. [PubMed] [Google Scholar]
  30. Suttie J. W. Vitamin K-dependent carboxylase. Annu Rev Biochem. 1985;54:459–477. doi: 10.1146/annurev.bi.54.070185.002331. [DOI] [PubMed] [Google Scholar]
  31. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990 Apr 20;61(2):203–212. doi: 10.1016/0092-8674(90)90801-k. [DOI] [PubMed] [Google Scholar]
  32. Varnum B. C., Young C., Elliott G., Garcia A., Bartley T. D., Fridell Y. W., Hunt R. W., Trail G., Clogston C., Toso R. J. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature. 1995 Feb 16;373(6515):623–626. doi: 10.1038/373623a0. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES